Introduction

62
Vpr is a highly conserved HIV accessory protein that is necessary for optimal replication in 63 macrophages (Balliet, Kolson et al. 1994 ) but its mechanism of action is poorly understood. on host proteins by western blot analysis, we utilized a replication defective HIV with a GFP 148 marker (NL4-3 ∆GPE-GFP) to allow measurement of MR expression via flow cytometry following 149 single-round transduction. This construct has the additional advantage that it eliminates 150 potentially confounding effects of differences in wild type and Vpr-null viral spread. Therefore, we 151 generated the necessary mutations in nef and vpr and confirmed that these mutations only 152 affected expression of the altered gene product in transfected HEK293T ( Figure 2B ). For 153 experiments in primary human macrophages, MDM were harvested at earlier times than the 154 experiments described in Figure 1 (five days versus ten days) because of the non-spreading 155 nature of the virus and the capacity to use flow cytometry to identify the subset of infected cells 156 by GFP expression ( Figure 2C ). Under these conditions, we found that MR expression was 157 dramatically reduced in a subset of GFP + cells when both Vpr and Nef were expressed ( Figure   158 2C-E). Loss of function mutations in either Vpr or Nef led to modest but statistically significant MR 
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To determine whether the modest effect of Nef alone was due to using HIV to deliver Nef as 166 compared to an adenoviral vector delivery system used in a prior publication (Vigerust, Egan et 
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While the effect of Nef has been previously reported and found to be due to disruption of MR 176 intracellular trafficking (Vigerust, Egan et al. 2005) , the effect of Vpr on MR has not been 177 previously reported. Vpr is known to target cellular proteins involved in DNA repair pathways for that Vpr in HEK293T cells had no effect on expression of MR controlled by a heterologous CMV 189 promoter ( Figure 2G and S1). Thus, we concluded that Vpr does not degrade MR by the direct 190 mechanism it uses to degrade UNG2 and SMUG1.
192
In addition to targeting proteins for degradation, Vpr also functions to inhibit transcription of genes 
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Combined effect of Vpr and Nef dramatically enhances Env levels in primary human MDM.
205
To determine whether the striking downmodulation of MR we observed with expression of both 206 Nef and Vpr affected viral spread in MR + macrophages, we generated additional mutations in HIV-207 1 89.6 to create a nef-null mutant and a vpr-nef-null double mutant. As expected, in transfected 208 HEK293T cells these mutations did not alter Env protein levels ( Figure 3A ) or release of virions 209 as assessed by measuring Gag p24 into the supernatant by ELISAs ( Figure 3B ). However, in 210 primary human MDM infected with these HIVs, the mutants demonstrated defects in viral spread,
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with the combination double mutant having the greatest defect ( Figure 3C and 3D). The defect in 212 spread was caused in part by diminished virion release, which we previously showed occurred in 
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To determine whether the striking downmodulation of MR we observed with expression of both 217 Nef and Vpr affected Env restriction in MR + macrophages, we assessed Env levels in primary 218 human MDM infected with each construct. Because the frequency of infected cells as assessed 219 by intracellular Gag staining ( Figure 3C ) and Gag pr55 expression as measured by western blot 220 was lower in the mutants than in the wild type infection ( Figure 3E ), lysate from the wild type 221 sample was serially diluted to facilitate comparisons. Remarkably, we found that the vpr-nef-null 222 double mutant, which retains near normal MR levels exhibited the greatest defect in Env including 2G12, to which YU-2 is highly resistant (Trkola, Purtscher et al. 1996) . We hypothesized 239 that loss of the mannose patch would decrease interactions with MR and reduce the requirement 240 for Vpr to counteract MDM-specific restrictions to virion release and Env expression. To test this 241 hypothesis we examined the extent to which virion release and Env expression were influenced 242 by Vpr in primary human MDM infected with YU-2 or 89.6 HIVs. Remarkably, we observed no 243 significant difference in Gag p24 release between wild type and vpr-null YU-2 infection of MDM 244 ( Figure 4A ). Moreover, the vpr-null mutant of YU2 displayed only a minor defect in Env expression 245 compared to Vpr null versions of 89.6 and NL4-3 ( Figure 4B ).
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Because there are a number of other genetic differences between YU-2 and the other HIVs, we 248 constructed a chimeric virus, which restricted the differences to the env open reading frame. As 249 shown in Figure 4C , a fragment of the YU-2 genome containing most of env but none of vpr 250 ( Figure 4C , shaded portion) was cloned into NL4-3 and NL4-3 vpr-null. As expected, these genetic 251 alterations did not affect Env protein levels or virion release in transfected HEK293T cells ( Figure   252 4D and E). To confirm that the chimeric Env was still functional, we examined infectivity in T cells 253 prior to performing our analyses in primary human MDM. Conveniently, sequence variation within 254 the gp120 region allows YU-2 Env to only utilize the co-receptor CCR5 for entry, whereas NL4-3 255 can only utilize CXCR4. Thus, we expected the NL4 3env YU2 chimera would switch from being 
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To determine whether swapping a limited portion of YU-2 containing Env into NL4-3 alleviated 265 the requirement for Vpr, we examined Env expression and virion release in primary human MDM 266 infected with these viruses. Because the parental NL4-3 virus required pseudotyping with a 267 macrophage-tropic Env for entry and was unable to spread in MDM, all infections were treated 268 with entry inhibitors AMD3100 and maraviroc 48 hours after inoculation to block subsequent 269 rounds of infection. Remarkably, we observed that wild type NL4-3 Env but not chimeric NL4-3 270 env YU2 required Vpr for maximal expression ( Figure 4G ). Moreover, MDM infected with the 271 chimeric HIV had a reduced requirement for Vpr for maximal virion release ( Figure 4H ). This 272 experiment provides strong evidence that the requirement for Vpr can be alleviated by genetic 
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To confirm that mutation of N230 and N339 disrupted the mannose patch on Env, we assayed 291 the ability of 2G12, which recognizes epitopes in the mannose patch (Sanders, Venturi et al. 2002, 292 Scanlan, Pantophlet et al. 2002) , to neutralize wild type and mutant Env. As shown in Figure 5D , 293 wild type but not mannose deficient N230D N339E was neutralized by 2G12. In addition, we found 294 that these substitutions did not disrupt infection of a T cell line that does not express MR ( Figure   295 5E). However, somewhat unexpectedly, we found that HIV containing the N230D N339E Env 296 substitutions were approximately 40% less infectious to primary human macrophages expressing 297 MR than the wild type parental virus ( Figure 5E ). This macrophage-specific difference in infectivity 298 suggested that mannose on Env facilitates initial infection through interactions with MR, which is 299 highly expressed on differentiated macrophages. To examine this possibility further, we asked 300 whether mannan, which competitively inhibits MR interactions with mannose containing glycans 301 (Shibata, Metzger et al. 1997) , was inhibitory to HIV infection. As a negative control, we tested 89.6 ∆env pseudotyped with vesicular stomatitls virus G-protein Env (VSV-G) which has only two 303 N-linked glycosylation sites, both of which contain complex-type rather than high-mannose 304 glycans (Reading, Penhoet et al. 1978 ) and therefore should not bind MR or be inhibited by 305 mannan. As expected, we found that infection of a T cell line lacking MR was not sensitive to 306 mannan ( Figure 5F , left panel). However, infection of MDM by wild type HIV-1 was inhibited up to 307 16-fold by mannan. This was specific to HIV Env because mannan did not inhibit infection by HIV 308 lacking env and pseudotyped with the heterologuos VSV-G Env ( Figure 5F ). Interestingly, 309 mannan also inhibited baseline macrophage infection by mannose-deficient Env (89.6 Env N230D 310 N339E), indicating that N230D N339E substitutions did not completely abrogate glycans on Env 311 that are beneifical to initial infection. In sum, our results demonstrate that interactions with 312 mannose binding receptors are advantageous for initial HIV infection of macrophages and that 313 the glycans remaining on Env N230D N339E retain some ability to bind glycan receptors on 314 macrophages that facilitate infection.
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While interactions between high-mannose residues on Env and MR are advantageous for viral 317 entry, we hypothesized that they interfered with intracellular Env trafficking and were deleterious 318 to egress of Env-containing virions in the absence of Vpr and/or Nef. To test this, we examined 319 virion release and Env expression by HIVs encoding the mannose-deficient Env N230D N339E 320 plus or minus Vpr expression. We found that mannose-deficient Env had a reduced requirement 321 for Vpr for maximal virus relase compared with the parental wild type virus in a spreading infection 322 system ( Figure 5G, p<0.001 ). In addition, the mannose-deficient Env had a reduced requirement 323 for both Nef and Vpr in virion release assays using primary human MDM infected for a single 324 round of infection ( Figure 5H , p<0.001). Single round infection assays were used to assess the 325 vpr-nef double mutant because depletion of mannose on Env did not rescue spread. This is likely 326 due to pleiotropic effects of Nef that disrupt interference by the HIV receptors, CD4, CXCR4 and 
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Finally, we asked whether the mannose-deficient Env had increased stability in primary human 331 MDM lacking Vpr and/or Nef by western blot analysis. Remarkably, we found that the mannose-332 deficient Env rescued Env expression in the absence of Vpr ( Figure 5I , right side, black bars), 333 and reduced the defect observed in the vpr-nef-null double mutant ( Figure 5I , right side, gray 334 bars) once differences in infection frequency were accounted for by matching pr55 expression in 335 the dilution series. These data provide strong support for the model that MR restricts Env 336 expression via direct interaction with high-mannose residues on Env and that this restriction is 337 counteracted by Vpr and Nef.
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Silencing MR alleviates restriction of Env in primary human MDM lacking Vpr. To directly 340 test the hypothesis that MR is the restriction factor in MDM that is counteracted by Vpr, we 341 examined the effect of MR silencing on Env expression in HIV-infected MDM lacking Vpr.
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Remarkably, we observed that silencing MR markedly reduced Env restriction -once differences 343 in infection frequency as assessed by Gag pr55 expression were accounted for ( Figure 6A ).
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These results support the conclusion that the Env restriction observed in vpr-null 89.6 is 345 dependent on expression of MR. whether MR was responsible for these defects in MDM lacking Vpr, we measured Vpr-dependent
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HIV-1 spread from primary human MDM silenced for MR to activated primary T cells freshly 353 isolated from the same donor. In this assay system, co-cultured cells were stained for CD3 to 354 distinguish T cells and CD14 to distinguish MDM as shown in Figure S2 . Indeed, we found that 355 silencing MR dramatically reduced the requirement for Vpr to support spread from MDM to T cells 356 ( Figure 6D ). In addition, MR silencing reduced the need for Vpr in virus release assays in the co-
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culture system ( Figure 6E ). These data support the conclusion that MR is the previously identified 
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7B, we observed that when T cells were cultured for two days with cell free virus without 373 spinnoculation, both T/F viruses failed to infect a significant fraction of T cells ( Figure 7C , upper 374 panel). In contrast, when T cells were co-cultured for two days with MDM that had previously been 375 infected as in Figure 6F 
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Indeed, we provide strong evidence that Env's interaction with MR boosts initial infection of MDM.
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This finding is supported by a prior report that MR enhances HIV-1 binding to macrophages and 456 transmission of the bound virus to co-cultured T cells (Nguyen and Hildreth 2003) . Our study adds 457 to these findings by providing evidence that interactions with mannose binding receptors also enhance direct infection of macrophages. Moreover, the capacity of Vpr and Nef to mitigate the 459 effect of detrimental intracellular interactions during viral egress limits the negative impact of 460 retaining high-mannose on Env. In addition, the dense glycan packing, which is privileged from 461 antibody recognition through immune tolerance, is believed to play a role in evasion of the 
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Monocytes were plated at 5x10 5 cells/well in a 24 well dish, except for those to be transduced 514 with lentivirus and puromycin selected, which were plated at 1 x10 6 cells/well. 
